Thermo Fisher Scientific Provides Update on Acquisition of Dionex

Published: May 10, 2011

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, is confident in being able to secure all necessary outstanding regulatory and antitrust approvals in connection with its previously announced tender offer to acquire all of the outstanding shares of Dionex Corporation (NASDAQ: DNEX) for $118.50 per share in cash.

Back to news